XML 26 R14.htm IDEA: XBRL DOCUMENT
v3.23.2

Share-Based Compensation | 6 Months Ended
--- | ---
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract] |
Share-Based Compensation | 9. Share-Based Compensation Equity Incentive Plan The Company’s 2020 Performance Incentive Plan (the "2020 Plan"), which was adopted by the Company’s board of directors in June 2020 and approved by the Company’s stockholders in July 2020, became effective upon the consummation of the Company’s initial public offering in July 2020 ("IPO"). Upon the effectiveness of the 2020 Plan, no further grants may be made under the Company’s 2015 Equity Incentive Plan (the "2015 Plan"). The 2020 Plan allows for the grant of incentive stock options, non-qualified stock options, stock appreciation rights, stock bonuses, restricted stock, stock units and other forms of awards including cash awards to its officers, directors, employees, consultants and advisors. As of June 30, 2023, a total of 8,388,917 shares of the Company’s common stock were authorized for issuance with respect to awards granted under the 2020 Plan (this number of shares gives effect to the annual increases in the 2020 Plan share limit, as described in the next sentence, through that date). The share limit will automatically increase on the first trading day in January of each year by an amount equal to the lesser of (1) 5% of the total number of outstanding shares of the Company’s common stock on the last trading day in December in the prior year, or (2) such lesser number as determined by the Company’s board of directors. Any shares subject to awards granted under the 2020 Plan or the 2015 Plan that are not paid, delivered or exercised before they expire or are canceled or terminated, or otherwise fail to vest, as well as shares used to pay the purchase or exercise price of such awards or related tax withholding obligations, will become available for new award grants under the 2020 Plan. A total of 2,535,547 shares were available for issuance under the 2020 Plan as of June 30, 2023. The following table summarizes the option activity under the 2020 Plan and 2015 Plan during the six months ended June 30, 2023:
|  | Number of shares |  |  | Weighted- average exercise price |  |  | Weighted- average remaining contractual term (in years) |
Outstanding at December 31, 2022 |  |  | 5,519,275 |  |  | $ | 17.17 |  |  |  | 8.1 |
Granted |  |  | 1,591,028 |  |  |  | 5.44 |  |  |  |
Exercised |  |  | (6,145 | ) |  |  | 3.61 |  |  |  |
Forfeited |  |  | (346,329 | ) |  |  | 15.08 |  |  |  |
Outstanding at June 30, 2023 |  |  | 6,757,829 |  |  | $ | 14.53 |  |  |  | 7.7 |
Exercisable at June 30, 2023 |  |  | 3,190,539 |  |  | $ | 16.68 |  |  |  | 6.5 |
Vested and expected to vest at June 30, 2023 |  |  | 6,757,829 |  |  | $ | 14.53 |  |  |  | 7.7 |
The weighted-average grant date fair value of stock option grants was $4.14 per share for the six months ended June 30, 2023. The following table summarizes the restricted stock unit activity under the 2020 Plan during the six months ended June 30, 2023:
|  | Number of shares |  |  | Weighted-average grant date fair value per share |
Outstanding at December 31, 2022 |  |  | 356,728 |  |  | $ | 12.66 |
Granted |  |  | 503,639 |  |  |  | 5.57 |
Vested |  |  | (78,543 | ) |  |  | 12.18 |
Forfeited |  |  | (64,868 | ) |  |  | 7.58 |
Outstanding at June 30, 2023 |  |  | 716,956 |  |  | $ | 8.19 |
Employee Stock Purchase Plan The Company’s 2020 Employee Stock Purchase Plan (the "ESPP"), which was adopted by the Company’s board of directors in June 2020 and approved by the Company’s stockholders in July 2020, became effective upon the consummation of the IPO. A total of 1,441,307 shares of the Company’s common stock were authorized for issuance under the ESPP. The ESPP allows eligible employees to purchase shares of the Company’s common stock at a discount through payroll deductions of up to 15% of their eligible compensation, subject to any plan limitations. The ESPP provides for six-month offering periods, and at the end of each offering period, employees are able to purchase shares at 85% of the lower of the fair market value of the Company’s common stock on the first trading day of the offering period or on the last trading day of the offering period. The six-month offering periods extend from June to November and December to May. As of June 30, 2023, 156,986 shares had been issued under the ESPP, and 1,284,321 shares remained available for issuance under the ESPP (after giving effect to share purchases under the ESPP through and including the offering period on May 31, 2023). As of June 30, 2023, employee contributions to the ESPP were $0.1 million and included as part of accrued and other current liabilities in the condensed balance sheets. Share-Based Compensation Expense Share-based compensation expense for the three and six ended June 30, 2023 and 2022 was as follows (in thousands):
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2023 |  |  | 2022 |  |  | 2023 |  |  | 2022 |
Research and development |  | $ | 2,123 |  |  | $ | 1,602 |  |  | $ | 4,205 |  |  | $ | 3,457 |
General and administrative |  |  | 2,527 |  |  |  | 2,310 |  |  |  | 5,191 |  |  |  | 4,552 |
Total share-based compensation |  | $ | 4,650 |  |  | $ | 3,912 |  |  | $ | 9,396 |  |  | $ | 8,009 |
The total unrecognized compensation cost related to unvested stock options was $29.3 million, which is expected to be recognized over a weighted-average remaining service period of 2.67 years as of June 30, 2023. The total unrecognized compensation cost related to unvested restricted stock units was $5.2 million, which is expected to be recognized over a weighted-average remaining service period of 3.26 years as of June 30, 2023. Liability for Early Exercise of Restricted Stock Options There were no shares subject to repurchase by the Company as of June 30, 2023. Shares subject to repurchase by the Company were 508 shares as of December 31, 2022, and the related liability recorded under other accrued and other current liabilities in the condensed balance sheet was insignificant.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration